OTC : ELMTY
$0 (0.0%)
| Source | Headline |
|---|---|
|
Elementis plc (ELMTY) Q2 2026 Earnings Call Transcript
Elementis plc (ELMTY) Q2 2026 Earnings Call Transcript seekingalpha.com - 2026-07-30 09:03:38 |
|
Elementis H1 Earnings Call Highlights
Elementis LON: ELM reported higher first-half revenue, profit and margins as the specialty chemicals company advanced its Elevate Elementis strategy, while management said it remains confident of meeting full-year 2026 expectations despite mixed market conditions. marketbeat.com - 2026-07-30 05:06:15 |
|
Elementis jumps after selling pharma manufacturing arm to AB Foods
Elementis plc (LSE:ELM) shares rose 6.2% to 161.2p after the speciality chemicals group completed the sale of its pharmaceutical manufacturing business to Associated British Foods PLC (LSE:ABF) and said it would return the proceeds to shareholders through a share buyback. The company confirmed completion of the disposal for an enterprise value of €34.3 million ($39.8 million) and, after transaction costs, expects to receive net cash proceeds of about €30 million (roughly $35 million), all of which will be returned to shareholders via a share repurchase programme that is expected to begin as soon as practicable. proactiveinvestors.co.uk - 2026-06-02 04:02:45 |
|
Artisan International Explorer Fund Q1 2026 Winners, Laggards, Buys And Sells
While the S&P 500® Index was largely flat in the first two months of the year, the MSCI ACWI ex US Small Cap Index jumped 11%. Our top three contributors in Q1 were IQE, Impro and Vitzrocell. Our top three detractors in Q1 were Alten, Signify and Elementis. seekingalpha.com - 2026-05-13 15:28:00 |